{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T13:42:11Z","timestamp":1794663731719,"version":"4.9.1"},"reference-count":69,"publisher":"American Society of Hematology","issue":"10","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,9,8]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>PTPRD lesions are among the most recurrent alterations in NMZL and appear to be enriched in this lymphoma type across mature B-cell tumors. NMZL and SMZL genetics overlap with the exceptions of PTPRD lesions, supporting their distinction as independent entities.<\/jats:p>","DOI":"10.1182\/blood-2016-02-696757","type":"journal-article","created":{"date-parts":[[2016,6,23]],"date-time":"2016-06-23T10:38:39Z","timestamp":1466678319000},"page":"1362-1373","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":167,"title":["The genetics of nodal marginal zone lymphoma"],"prefix":"10.1182","volume":"128","author":[{"given":"Valeria","family":"Spina","sequence":"first","affiliation":[{"name":"Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Khiabanian","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics and Systems Biology, Columbia University, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Messina","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Monti","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Cascione","sequence":"additional","affiliation":[{"name":"Institute of Oncology Research and Oncology Institute of Southern Switzerland, Bellinzona, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Bruscaggin","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Spaccarotella","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antony B.","family":"Holmes","sequence":"additional","affiliation":[{"name":"Institute for Cancer Genetics and the Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Arcaini","sequence":"additional","affiliation":[{"name":"Department of Hematology-Oncology, Fondazione IRCCS Policlinico San Matteo and Department of Molecular Medicine, University of Pavia, Pavia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Lucioni","sequence":"additional","affiliation":[{"name":"Division of Pathology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Tabb\u00f2","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakellarios","family":"Zairis","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics and Systems Biology, Columbia University, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fary","family":"Diop","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Cerri","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Chiaretti","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Marasca","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Oncology and Hematology, University of Modena and Reggio Emilia, Modena, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurilio","family":"Ponzoni","sequence":"additional","affiliation":[{"name":"Ateneo Vita-Salute and Unit of Lymphoid Malignancies, San Raffaele H. Scientific Institute, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Deaglio","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, University of Torino and Immunogenetics Unit, Human Genetics Foundation, Torino, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Ramponi","sequence":"additional","affiliation":[{"name":"Division of Pathology, Department of Health Sciences, Amedeo Avogadro University of Eastern Piedmont and Maggiore Hospital, Novara, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Tiacci","sequence":"additional","affiliation":[{"name":"Institute of Hematology, Ospedale S. Maria della Misericordia, University of Perugia, Perugia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Pasqualucci","sequence":"additional","affiliation":[{"name":"Institute for Cancer Genetics and the Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Paulli","sequence":"additional","affiliation":[{"name":"Division of Pathology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brunangelo","family":"Falini","sequence":"additional","affiliation":[{"name":"Institute of Hematology, Ospedale S. Maria della Misericordia, University of Perugia, Perugia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Inghirami","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY;"},{"name":"Department of Molecular Biotechnology and Health Science and Center for Experimental Research and Medical Studies, University of Torino, Torino, Italy; and"},{"name":"Department of Pathology, NYU Cancer Center, New York University School of Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bertoni","sequence":"additional","affiliation":[{"name":"Institute of Oncology Research and Oncology Institute of Southern Switzerland, Bellinzona, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Fo\u00e0","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul","family":"Rabadan","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics and Systems Biology, Columbia University, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Gaidano","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Rossi","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy;"},{"name":"Institute of Oncology Research and Oncology Institute of Southern Switzerland, Bellinzona, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111902280523300_B1","article-title":"World Health Organization Classification of Tumours, Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues.","author":"Swerdlow","year":"2008"},{"issue":"5","key":"2019111902280523300_B2","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1365-2559.2012.04289.x","article-title":"IRTA1 is selectively expressed in nodal and extranodal marginal zone lymphomas.","volume":"61","author":"Falini","year":"2012","journal-title":"Histopathology"},{"issue":"10","key":"2019111902280523300_B3","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1182\/blood-2003-03-0750","article-title":"Expression of the IRTA1 receptor identifies intraepithelial and subepithelial marginal zone B cells of the mucosa-associated lymphoid tissue (MALT).","volume":"102","author":"Falini","year":"2003","journal-title":"Blood"},{"issue":"4","key":"2019111902280523300_B4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/MOH.0b013e3283477815","article-title":"Non-MALT marginal zone lymphoma.","volume":"18","author":"Thieblemont","year":"2011","journal-title":"Curr Opin Hematol"},{"issue":"9","key":"2019111902280523300_B5","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1084\/jem.20120904","article-title":"The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development.","volume":"209","author":"Rossi","year":"2012","journal-title":"J Exp Med"},{"issue":"9","key":"2019111902280523300_B6","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1084\/jem.20120910","article-title":"Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma.","volume":"209","author":"Kiel","year":"2012","journal-title":"J Exp Med"},{"issue":"6","key":"2019111902280523300_B7","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/leu.2013.365","article-title":"Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation.","volume":"28","author":"Mart\u00ednez","year":"2014","journal-title":"Leukemia"},{"issue":"2","key":"2019111902280523300_B8","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/leu.2014.294","article-title":"The Kr\u00fcppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma.","volume":"29","author":"Piva","year":"2015","journal-title":"Leukemia"},{"issue":"5","key":"2019111902280523300_B9","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/leu.2014.330","article-title":"KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype.","volume":"29","author":"Clipson","year":"2015","journal-title":"Leukemia"},{"issue":"18","key":"2019111902280523300_B10","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1158\/1078-0432.CCR-14-2759","article-title":"Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep Sequencing.","volume":"21","author":"Parry","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"18","key":"2019111902280523300_B11","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1182\/blood-2011-06-359166","article-title":"Alteration of BIRC3 and multiple other NF-\u03baB pathway genes in splenic marginal zone lymphoma.","volume":"118","author":"Rossi","year":"2011","journal-title":"Blood"},{"issue":"Suppl 2","key":"2019111902280523300_B12","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/1752-0509-7-S2-S2","article-title":"SAVI: a statistical algorithm for variant frequency identification.","volume":"7","author":"Trifonov","year":"2013","journal-title":"BMC Syst Biol"},{"issue":"12","key":"2019111902280523300_B13","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/ng.3442","article-title":"The mutational landscape of cutaneous T cell lymphoma and S\u00e9zary syndrome.","volume":"47","author":"da Silva Almeida","year":"2015","journal-title":"Nat Genet"},{"issue":"1","key":"2019111902280523300_B14","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.celrep.2013.12.027","article-title":"Genetics of follicular lymphoma transformation.","volume":"6","author":"Pasqualucci","year":"2014","journal-title":"Cell Reports"},{"issue":"4","key":"2019111902280523300_B15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ng.2900","article-title":"Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma.","volume":"46","author":"Gunawardana","year":"2014","journal-title":"Nat Genet"},{"issue":"11","key":"2019111902280523300_B16","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.3324\/haematol.2011.041921","article-title":"Mutation analysis of the tyrosine phosphatase PTPN2 in Hodgkin\u2019s lymphoma and T-cell non-Hodgkin\u2019s lymphoma.","volume":"96","author":"Kleppe","year":"2011","journal-title":"Haematologica"},{"issue":"20","key":"2019111902280523300_B17","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1182\/blood-2009-06-225839","article-title":"Inactivating SOCS1 mutations are caused by aberrant somatic hypermutation and restricted to a subset of B-cell lymphoma entities.","volume":"114","author":"Mottok","year":"2009","journal-title":"Blood"},{"issue":"9","key":"2019111902280523300_B18","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1182\/blood-2013-10-531509","article-title":"A targeted mutational landscape of angioimmunoblastic T-cell lymphoma.","volume":"123","author":"Odejide","year":"2014","journal-title":"Blood"},{"issue":"4","key":"2019111902280523300_B19","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1182\/blood-2014-06-582650","article-title":"Activating STAT6 mutations in follicular lymphoma.","volume":"125","author":"Yildiz","year":"2015","journal-title":"Blood"},{"issue":"4","key":"2019111902280523300_B20","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ccell.2015.03.006","article-title":"Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma.","volume":"27","author":"Crescenzo","year":"2015","journal-title":"Cancer Cell"},{"issue":"3","key":"2019111902280523300_B21","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/bioinformatics\/btn624","article-title":"Reference alignment of SNP microarray signals for copy number analysis of tumors.","volume":"25","author":"Pounds","year":"2009","journal-title":"Bioinformatics"},{"issue":"9","key":"2019111902280523300_B22","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ng.892","article-title":"Analysis of the coding genome of diffuse large B-cell lymphoma.","volume":"43","author":"Pasqualucci","year":"2011","journal-title":"Nat Genet"},{"key":"2019111902280523300_B23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12918-014-0097-z","article-title":"Pegasus: a comprehensive annotation and prediction tool for detection of driver gene fusions in cancer.","volume":"8","author":"Abate","year":"2014","journal-title":"BMC Syst Biol"},{"issue":"8","key":"2019111902280523300_B24","doi-asserted-by":"crossref","first-page":"R72","DOI":"10.1186\/gb-2011-12-8-r72","article-title":"TopHat-Fusion: an algorithm for discovery of novel fusion transcripts.","volume":"12","author":"Kim","year":"2011","journal-title":"Genome Biol"},{"issue":"16","key":"2019111902280523300_B25","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1093\/bioinformatics\/bts356","article-title":"RSeQC: quality control of RNA-seq experiments.","volume":"28","author":"Wang","year":"2012","journal-title":"Bioinformatics"},{"issue":"5","key":"2019111902280523300_B26","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nbt.1621","article-title":"Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation.","volume":"28","author":"Trapnell","year":"2010","journal-title":"Nat Biotechnol"},{"issue":"7","key":"2019111902280523300_B27","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies.","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"43","key":"2019111902280523300_B28","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019111902280523300_B29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.0105-2896.2006.00373.x","article-title":"A library of gene expression signatures to illuminate normal and pathological lymphoid biology.","volume":"210","author":"Shaffer","year":"2006","journal-title":"Immunol Rev"},{"issue":"13","key":"2019111902280523300_B30","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1158\/1078-0432.CCR-08-3266","article-title":"Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome.","volume":"15","author":"Rossi","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"5","key":"2019111902280523300_B31","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nbt.2203","article-title":"Absolute quantification of somatic DNA alterations in human cancer.","volume":"30","author":"Carter","year":"2012","journal-title":"Nat Biotechnol"},{"issue":"4","key":"2019111902280523300_B32","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nmeth.2883","article-title":"PyClone: statistical inference of clonal population structure in cancer.","volume":"11","author":"Roth","year":"2014","journal-title":"Nat Methods"},{"issue":"1","key":"2019111902280523300_B33","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.celrep.2012.12.008","article-title":"Deciphering signatures of mutational processes operative in human cancer.","volume":"3","author":"Alexandrov","year":"2013","journal-title":"Cell Reports"},{"issue":"12","key":"2019111902280523300_B34","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1084\/jem.20120833","article-title":"Cellular origin and pathophysiology of chronic lymphocytic leukemia.","volume":"209","author":"Seifert","year":"2012","journal-title":"J Exp Med"},{"issue":"9","key":"2019111902280523300_B35","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1200\/JCO.2008.20.9759","article-title":"Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms.","volume":"28","author":"Piva","year":"2010","journal-title":"J Clin Oncol"},{"issue":"7339","key":"2019111902280523300_B36","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nature09837","article-title":"Initial genome sequencing and analysis of multiple myeloma.","volume":"471","author":"Chapman","year":"2011","journal-title":"Nature"},{"issue":"7360","key":"2019111902280523300_B37","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10351","article-title":"Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma.","volume":"476","author":"Morin","year":"2011","journal-title":"Nature"},{"issue":"1","key":"2019111902280523300_B38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ng.1032","article-title":"Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia.","volume":"44","author":"Quesada","year":"2011","journal-title":"Nat Genet"},{"issue":"26","key":"2019111902280523300_B39","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1109016","article-title":"SF3B1 and other novel cancer genes in chronic lymphocytic leukemia.","volume":"365","author":"Wang","year":"2011","journal-title":"N Engl J Med"},{"issue":"12","key":"2019111902280523300_B40","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/ng.2469","article-title":"Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing.","volume":"44","author":"Richter","year":"2012","journal-title":"Nat Genet"},{"issue":"7418","key":"2019111902280523300_B41","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature11378","article-title":"Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics.","volume":"490","author":"Schmitz","year":"2012","journal-title":"Nature"},{"issue":"9","key":"2019111902280523300_B42","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMoa1200710","article-title":"MYD88 L265P somatic mutation in Waldenstr\u00f6m\u2019s macroglobulinemia.","volume":"367","author":"Treon","year":"2012","journal-title":"N Engl J Med"},{"issue":"45","key":"2019111902280523300_B43","doi-asserted-by":"crossref","first-page":"18250","DOI":"10.1073\/pnas.1314608110","article-title":"Landscape of somatic mutations and clonal evolution in mantle cell lymphoma.","volume":"110","author":"Be\u00e0","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"2019111902280523300_B44","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cell.2013.01.019","article-title":"Evolution and impact of subclonal mutations in chronic lymphocytic leukemia.","volume":"152","author":"Landau","year":"2013","journal-title":"Cell"},{"issue":"7","key":"2019111902280523300_B45","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1182\/blood-2013-02-483727","article-title":"Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing.","volume":"122","author":"Morin","year":"2013","journal-title":"Blood"},{"issue":"11","key":"2019111902280523300_B46","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1182\/blood-2013-09-525808","article-title":"The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis.","volume":"123","author":"Hunter","year":"2014","journal-title":"Blood"},{"issue":"10","key":"2019111902280523300_B47","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1073\/pnas.1121343109","article-title":"Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing.","volume":"109","author":"Lohr","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"2019111902280523300_B48","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ng.2856","article-title":"Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma.","volume":"46","author":"Okosun","year":"2014","journal-title":"Nat Genet"},{"issue":"7574","key":"2019111902280523300_B49","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature14666","article-title":"Non-coding recurrent mutations in chronic lymphocytic leukaemia.","volume":"526","author":"Puente","year":"2015","journal-title":"Nature"},{"issue":"7463","key":"2019111902280523300_B50","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer.","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"issue":"26","key":"2019111902280523300_B51","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.1200\/JCO.2005.05.011","article-title":"Molecular pathogenesis of mucosa-associated lymphoid tissue lymphoma.","volume":"23","author":"Farinha","year":"2005","journal-title":"J Clin Oncol"},{"issue":"3","key":"2019111902280523300_B52","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/leu.2014.264","article-title":"The mutational pattern of primary lymphoma of the central nervous system determined by whole-exome sequencing.","volume":"29","author":"Vater","year":"2015","journal-title":"Leukemia"},{"issue":"19","key":"2019111902280523300_B53","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1158\/1078-0432.CCR-12-0845","article-title":"Recurrent mutations of MYD88 and TBL1XR1 in primary central nervous system lymphomas.","volume":"18","author":"Gonzalez-Aguilar","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"17","key":"2019111902280523300_B54","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1158\/1078-0432.CCR-14-2116","article-title":"Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas.","volume":"21","author":"Braggio","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"6","key":"2019111902280523300_B55","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00401-016-1536-2","article-title":"Genomic characterization of primary central nervous system lymphoma.","volume":"131","author":"Fukumura","year":"2016","journal-title":"Acta Neuropathol"},{"issue":"23","key":"2019111902280523300_B56","doi-asserted-by":"crossref","first-page":"9435","DOI":"10.1073\/pnas.0900571106","article-title":"The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers.","volume":"106","author":"Veeriah","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"2019111902280523300_B57","first-page":"1301","article-title":"Mutational and functional analysis of the tumor-suppressor PTPRD in human melanoma.","volume":"35","author":"Walia","year":"2014","journal-title":"Hum Mutat"},{"issue":"7216","key":"2019111902280523300_B58","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature07423","article-title":"Somatic mutations affect key pathways in lung adenocarcinoma.","volume":"455","author":"Ding","year":"2008","journal-title":"Nature"},{"issue":"5674","key":"2019111902280523300_B59","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1126\/science.1096096","article-title":"Mutational analysis of the tyrosine phosphatome in colorectal cancers.","volume":"304","author":"Wang","year":"2004","journal-title":"Science"},{"issue":"12","key":"2019111902280523300_B60","doi-asserted-by":"crossref","first-page":"6722","DOI":"10.1074\/jbc.270.12.6722","article-title":"Molecular characterization of the human transmembrane protein-tyrosine phosphatase delta. Evidence for tissue-specific expression of alternative human transmembrane protein-tyrosine phosphatase delta isoforms.","volume":"270","author":"Pulido","year":"1995","journal-title":"J Biol Chem"},{"issue":"22","key":"2019111902280523300_B61","doi-asserted-by":"crossref","first-page":"8149","DOI":"10.1073\/pnas.1401952111","article-title":"Loss of the tyrosine phosphatase PTPRD leads to aberrant STAT3 activation and promotes gliomagenesis.","volume":"111","author":"Ortiz","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"2019111902280523300_B62","doi-asserted-by":"crossref","first-page":"e0135750","DOI":"10.1371\/journal.pone.0135750","article-title":"Loss-of-Function PTPRD Mutations Lead to Increased STAT3 Activation and Sensitivity to STAT3 Inhibition in Head and Neck Cancer.","volume":"10","author":"Peyser","year":"2015","journal-title":"PLoS One"},{"issue":"16","key":"2019111902280523300_B63","doi-asserted-by":"crossref","first-page":"6976","DOI":"10.18632\/oncotarget.2106","article-title":"Deletion of Ptprd and Cdkn2a cooperate to accelerate tumorigenesis.","volume":"5","author":"Ortiz","year":"2014","journal-title":"Oncotarget"},{"issue":"2","key":"2019111902280523300_B64","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1073\/pnas.1013168108","article-title":"Kr\u00fcppel-like factor 2 (KLF2) regulates B-cell reactivity, subset differentiation, and trafficking molecule expression.","volume":"108","author":"Hart","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"2019111902280523300_B65","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nri2656","article-title":"The follicular versus marginal zone B lymphocyte cell fate decision.","volume":"9","author":"Pillai","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"2019111902280523300_B66","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1182\/blood-2010-01-264275","article-title":"Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome.","volume":"117","author":"Rinaldi","year":"2011","journal-title":"Blood"},{"issue":"1","key":"2019111902280523300_B67","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00000478-199901000-00006","article-title":"Primary nodal marginal zone lymphomas of splenic and MALT type.","volume":"23","author":"Campo","year":"1999","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"2019111902280523300_B68","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/00000478-200306000-00006","article-title":"Nodal marginal zone lymphoma: a heterogeneous tumor: a comprehensive analysis of a series of 27 cases.","volume":"27","author":"Camacho","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"2019111902280523300_B69","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3324\/haematol.2012.083386","article-title":"Recognizing nodal marginal zone lymphoma: recent advances and pitfalls. A systematic review.","volume":"98","author":"van den Brand","year":"2013","journal-title":"Haematologica"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/128\/10\/1362\/1395083\/1362.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/128\/10\/1362\/1395083\/1362.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T02:28:35Z","timestamp":1574130515000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/128\/10\/1362\/35315\/The-genetics-of-nodal-marginal-zone-lymphoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,8]]},"references-count":69,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,9,8]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2016-02-696757","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,8]]}}}